MIT Recognizes 9 Innovators Under 35 in Biotech

MIT Technology Review has announced its annual list of 35 Innovators Under 35, recognizing individuals under the age of 35 whose research and technical work are poised to shape the future of science and technology. This year's selection prominently features nine individuals making significant advancements in the field of biotechnology, with their work spanning life-saving innovations and groundbreaking "age reversal" technologies. These honorees represent a diverse range of contributions aimed at addressing critical health challenges and pushing the boundaries of biological understanding.

Among the featured innovators is Paschal Kija, a 28-year-old who has developed a device to combat postpartum hemorrhage, a leading cause of maternal deaths in his home country of Tanzania. Kija's innovation, named Mkanda Salama, which translates to "Safe Wrap" in Swahili, is designed for ease of use and affordability, costing approximately $70. Clinical studies have demonstrated its effectiveness, with research indicating that the device successfully stopped postpartum bleeding in 73% of women within 20 minutes of application. This development holds significant potential for reducing maternal mortality rates in regions where access to advanced medical interventions is limited.

Another notable innovator is Xiao Yang, 34, who is revolutionizing the development of brain electrodes. Traditional brain electrodes, while crucial for understanding brain activity and treating neurological disorders, can cause damage to surrounding brain tissue due to their invasive nature. Yang is creating ultra-small, flexible electrodes that mimic the structure of neurons, aiming to minimize impact on brain tissue. Her work is inspired by kirigami, the Japanese art of paper cutting, which she has applied to design a honeycombed, spiral basket-shaped sheet of electrodes. This novel design allows for the study of brain cells in the lab with unprecedented detail and reduced invasiveness.

The list also acknowledges Sarah Grandinette for her contributions to developing treatments for rare genetic disorders. In 2024, Grandinette was part of a team working on a case involving Kyle "KJ" Muldoon Jr., who was born with a rare and potentially fatal genetic disorder. The specific details of the treatment developed by Grandinette and her team for KJ Muldoon Jr. are part of a broader effort to create new therapeutic strategies for conditions that currently have limited or no effective treatments. The inclusion of these innovators underscores the rapid pace of progress in biotechnology and the critical role of young researchers in driving future medical breakthroughs.